Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1059-1066
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1059
Figure 3
Figure 3 Effects of rebamipide on small intestinal malondialdehyde content and myeloperoxidase activity. Values are mean ± SEM of data obtained from 8 mice in each group. aP < 0.05, bP < 0.01 compared with the diclofenac group. MDA: Malondialdehyde; MPO: Myeloperoxidase.